Photo of Carmen Calfa from Sylvester Comprehensive Cancer Center/X
Sep 11, 2024, 10:37
How germline testing can guide screening and treatment options – Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center shared a post on X:
“Genetic and genomic testing can significantly impact your treatment. Dr. Carmen Calfa highlights a 42% drop in Breast Cancer mortality over 30 years. Learn how germline testing can guide screening and treatment options.”
Source: Sylvester Comprehensive Cancer Center/X
Dr. Carmen Calfa is the Medical Co-Director of the Cancer Survivorship Program at Sylvester Comprehensive Cancer Center and a Breast Medical Oncologist at Sylvester Cancer Center, UHealth. She also serves as the Associate Director of Community Outreach for the Sylvester Breast Program at Plantation, University of Miami Miller School of Medicine.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14